Celyad SA

CYAD Healthcare Biotechnology

Celyad SA’s revenue for fiscal 2025 (year ended December 2025) was $23,800.00, down 88.2% from fiscal 2024.

Market cap
$23.8M
P/E
0.0×
Fwd P/E
−2.3×
Dividend yield
—
F-score
3/9
Altman Z
n/a
Beneish M
10.49
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
91.39 38.32 58.74 44.06 19.69 35.51 13.11 7.58 4.54 1.93
Receivables
1.50 0.26 0.43 2.51 0.87 2.44 1.18 2.94 0.86 0.85
Inventory
0.68 — — — — — — — 0.45 —
Other current assets
1.57 2.55 1.87 1.40 1.95 2.62 1.33 1.52 1.19 1.17
Total current assets
94.47 41.14 61.05 47.98 22.51 40.57 15.62 12.04 7.05 3.96
Property, Plant, Equpment (Net)
3.94 3.72 3.56 5.67 4.71 3.84 0.33 1.98 1.62 —
Long-Term Investments
0.33 0.33 — 3.42 — — — — — —
Long-term receivables
— — 2.06 2.72 6.62 7.07 3.64 3.03 1.54 0.85
Goodwill and Intangible Assets (Total)
54.85 41.27 42.71 40.54 41.32 42.79 0.91 0.42 0.44 0.02
Long-term assets (Other)
0.34 1.62 1.99 0.29 0.33 0.31 0.28 0.15 0.10 0.04
Total non-current assets
59.14 46.60 50.32 52.64 52.98 54.01 5.15 5.59 3.69 0.91
Total Assets
153.60 87.74 111.37 100.62 75.49 94.58 20.77 17.62 10.74 4.86
Accounts Payable
8.96 5.43 6.99 7.81 5.41 7.82 5.01 1.35 1.33 0.58
Current Part of Debt
0.23 0.24 0.33 0.22 0.04 — — — — —
Current Part of Capital Lease
0.39 0.48 0.57 1.31 1.23 1.07 0.14 0.17 0.15 —
Other current liabilities
1.67 2.58 3.18 3.64 6.84 7.47 5.83 1.66 1.59 1.37
Total current liabilities
12.48 8.98 11.39 13.35 13.52 16.36 10.98 3.17 3.08 2.06
Long Term Debt (Total)
1.01 0.91 1.04 3.36 2.88 2.05 0.12 0.98 0.83 —
Pension and Post-Retirement Liabilities
0.23 0.23 0.15 0.45 0.70 0.06 0.01 0.00 0.00 0.00
Non-current Liabilities (Other)
39.31 23.89 33.13 32.36 22.98 24.48 5.10 6.65 6.28 0.05
Total non-current liabilities
40.55 25.03 34.32 36.17 26.57 26.59 5.24 7.63 7.11 0.05
Total liabilities
53.03 34.01 45.72 49.52 40.08 42.95 16.22 10.80 10.19 2.11
Additional Paid In Capital
174.85 192.49 243.46 48.55 49.52 7.47 6.66 — — —
Common Stock (Net)
36.04 38.81 49.07 54.33 55.42 92.97 82.80 35.66 8.89 10.43
Retained Earnings
(137.25) (203.93) (257.20) (83.35) (104.89) (365.57) (368.70) (387.87) (394.10) (411.11)
Shareholders Equity (Other)
26.92 26.36 30.31 31.56 35.36 316.76 283.80 359.03 385.76 403.44
Common Equity (Total)
100.57 53.73 65.65 51.09 35.40 51.63 4.55 6.82 0.55 2.76
Shareholders Equity (Total)
100.57 53.73 65.65 51.09 35.40 51.63 4.55 6.82 0.55 2.76
Shareholders Equity and Liabilities (Total)
153.60 87.74 111.37 100.62 75.49 94.58 20.77 17.62 10.74 4.86
Shares (Common)
9.31 9.87 11.94 13.94 13.94 22.59 22.59 41.43 41.43 44.76
Shareholders Equity (Tangible)
45.72 12.46 22.94 10.55 (5.91) 8.84 3.64 6.40 0.11 2.74
Net Debt
(90.15) (37.17) (57.37) (40.48) (16.76) (33.47) (12.99) (6.60) (3.72) (1.93)
Total Debt
1.24 1.15 1.37 3.58 2.93 2.05 0.12 0.98 0.83 —

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 14 Oct 2026